Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E6.53 EPS (ttm)6.09 Insider Own- Shs Outstand2.39B Perf Week5.88%
Market Cap94.99B Forward P/E15.40 EPS next Y2.58 Insider Trans- Shs Float2.39B Perf Month0.20%
Income14.68B PEG0.80 EPS next Q0.56 Inst Own9.60% Short Float0.13% Perf Quarter-2.55%
Sales35.44B P/S2.68 EPS this Y-48.70% Inst Trans0.08% Short Ratio0.79 Perf Half Y-13.89%
Book/sh4.38 P/B9.08 EPS next Y11.34% ROA20.00% Target Price45.83 Perf Year-8.43%
Cash/sh4.95 P/C8.03 EPS next 5Y8.20% ROE164.20% 52W Range37.24 - 47.81 Perf YTD-3.07%
Dividend2.31 P/FCF- EPS past 5Y-12.10% ROI15.00% 52W High-16.82% Beta0.80
Dividend %5.81% Quick Ratio1.00 Sales past 5Y-4.10% Gross Margin68.20% 52W Low6.79% ATR0.82
Employees98702 Current Ratio1.30 Sales Q/Q5.90% Oper. Margin21.10% RSI (14)48.38 Volatility1.68% 1.74%
OptionableYes Debt/Eq2.52 EPS Q/Q-78.60% Profit Margin42.40% Rel Volume0.69 Prev Close39.96
ShortableYes LT Debt/Eq2.15 EarningsOct 28 Payout38.90% Avg Volume3.85M Price39.77
Recom2.50 SMA200.94% SMA50-3.28% SMA200-7.81% Volume2,653,056 Change-0.48%
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Oct-23-09Downgrade Jefferies & Co Buy → Hold
Mar-17-09Initiated Credit Suisse Outperform
Jan-26-09Initiated Jefferies & Co Buy
Oct-06-15 01:17PM  Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line? at Motley Fool
07:00AM  Axovant begins large late-stage trials for Alzheimer's drug at Financial Times
12:58AM  Bristol-Myers to pay $14m to settle China bribery claim at Financial Times
12:14AM  How Much Should Scientists Check Other Scientists Work? at The Wall Street Journal
Oct-05-15 02:12PM  Falling Energy Prices Subdue the Eurozones September Inflation
05:29AM  Should You Buy BP plc And GlaxoSmithKline plc For Your Income Portfolio?
Oct-01-15 08:40AM  GlaxoSmithKline puts Parkway West office campus up for sale at
Sep-30-15 06:06PM  Sanofis Profitability Improved in 2Q15
05:06PM  How Did Sanofi Pasteur Perform in 2Q15?
03:05PM  GSK reaches exclusive deal for technology developed by UNC spinout at
11:14AM  SABMiller Rises 1.30% on Proposed Takeover Bid by Anheuser-Busch
09:04AM  4 Of The Best Income Stocks Around: GlaxoSmithKline plc, Standard Life Plc, SSE PLC And Centrica plc
Sep-28-15 05:17PM  Martin Shkreli A Creature Of FDA Regulation, Not Pharma Industry's Greed at Forbes
08:42AM  Clinton Proposals Could Spell Trouble for These 3 Drugmakers at Motley Fool
04:02AM  Will GlaxoSmithKline plc's Global Ambitions Make It A Buy?
Sep-26-15 08:03AM  3 Stocks We're Ready to Sell at Motley Fool
Sep-25-15 04:52PM  GlaxoSmithKline (GSK) Stock: Is the Worst Over? at TheStreet
04:25PM  Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing
06:25AM  Research and Markets: Investigation Report on China's Cefuroxime Market, 2010-2019 Business Wire
Sep-24-15 11:17AM  EU regulator backs approval for GSK injectable asthma drug Reuters
10:20AM  Only weeks old, RTP's Phoundry acquired by Boston firm at
09:41AM  Axovant Full of Sound, Signifying Nothing Much Really at Forbes
03:33AM  Neil Woodford Still Believes in AstraZeneca plc And GlaxoSmithKline plc. Should you?
03:07AM  Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan Marketwired
Sep-23-15 11:02AM  GSK may get EU green light for new biotech asthma drug this week Reuters
05:27AM  New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq® Maintains HIV Viral Suppression PR Newswire
Sep-22-15 07:04AM  Whats the Outlook for Eli Lilly?
Sep-21-15 04:48PM  Hillary Clinton Is Why Biotech Is Falling at Motley Fool
02:43PM  Here's A Way For Pharma To Prevent Outrageous Generic Price Increases -- And Help Its Reputation at Forbes
12:00PM  Eli Lilly (LLY) Stock, Full of Life With a 30% Upside at TheStreet
Sep-19-15 03:00AM  Should I Pile Into Neil Woodford Picks GlaxoSmithKline plc, British American Tobacco plc And BT Group plc?
Sep-18-15 07:00AM  Science said Paxil, a popular antidepressant, was safe for teensand then changed its mind
05:54AM  GlaxoSmithKline plc Could Return To 1,600p By The End Of The Year!
Sep-16-15 12:02PM  There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance at Motley Fool
08:07AM  Is Patience Really A Virtue For Investors In Aviva plc, GlaxoSmithKline plc And Unilever plc?
Sep-13-15 12:57AM  Guru Stocks at 52-Week Lows: RDS.A, PTR, UL, BP, GSK
Sep-12-15 01:33PM  GlaxoSmithKline's 'Unexpected Disappointment'
07:38AM  Big Pharma's 3 Most Perilous Pipelines at Motley Fool
Sep-11-15 01:26PM  Video: VIX traders position for Fed
12:18PM  GlaxoSmithKline draws upside bet
11:12AM  EWU Rises over Draghis Comment on the ECBs Asset-Buying Program
Sep-10-15 10:14AM  The new vaccine that could mean the end of malaria at MarketWatch
07:45AM  Whos on? Whos off? Fortunes list of the Most Powerful Women has plenty of changes at Fortune
05:48AM  GlaxoSmithKline plc, Genus plc And Alliance Pharma plc: 3 Of The Best Health Care Stocks?
Sep-09-15 07:48PM  PRESS DIGEST- Financial Times - Sept 10
05:17PM  Why Theravance Inc. Shares Crashed 21% Today at Motley Fool
04:05PM  Theravance, Glaxo SUMMIT Study Misses Primary Endpoint
01:45PM  Theravance Just Lost Its Catalyst
12:55PM  Is Axovant's Alzheimer's Drug The Real Deal, Or A Phantasm? at Forbes
12:48PM  European shares hit two-week high, miners boost
12:16PM  FTSE 100 closes with third day of gains at MarketWatch
11:34AM  Smart Money Dont Bet on Three Biotech Stocks that Slumped Today and You Should Not Too at Insider Monkey
10:00AM  The 30-Year-Old CEO Conjuring Drug Companies From Thin Air at Forbes
10:00AM  A setback for GSK
07:15AM  Rally in miners helps European shares hit two-week high
06:19AM  European Stocks Upbeat as Asia Rallies; Nikkei Jumps 7.7% at TheStreet
04:19AM  Respiratory drug trial failure deals blow to GSK revival plan at Financial Times
04:19AM  European shares boosted by Ryanair after profit forecast hike
03:57AM  Glaxo Asthma Drug Stumbles in Ambitious Heart Patient Study at Bloomberg
Sep-08-15 06:12PM  GlaxoSmithKline Inhaler Trial Fails to Show Extension of Life at The Wall Street Journal
06:11PM  Study finds key GSK-Theravance lung drug didn't extend lives
02:40PM  GSK and Theravance Announce Results From the SUMMIT COPD CV Survival Study Marketwired
01:07PM  What Were Merck & Co.s Profitability Margins?
10:24AM  Why GlaxoSmithKline plc, BT Group plc And Travis Perkins plc Offer Unmissable Value For Money!
09:49AM  Research and Markets: Investigation Report on China's Atracurium Market 2010-2015 & 2019-2019 Business Wire
Sep-07-15 06:26AM  Why GlaxoSmithKline plc, BAE Systems plc And WPP PLC ORD 10P Are At The Top Of My Buy List
Sep-04-15 02:27PM  Probes Reporter's Latest Updates: Choice Hotels, GlaxoSmithKline, Itron, Kinross Gold And More
10:37AM  3 Neil Woodford High Yield Picks: GlaxoSmithKline plc, Centrica PLC And Legal & General Group Plc
08:44AM  1 Big Pharma Stock to Buy, 1 to Sell at Motley Fool
Sep-03-15 09:56AM  Gilead's F/TAF Positive Results And Why They Are Significant at Forbes
09:07AM  Financial Services Take EWU Down
05:52AM  Despite Recent Declines, I'm Still Buying Royal Dutch Shell Plc And GlaxoSmithKline plc
Sep-02-15 04:19AM  Why Value Is Up for Grabs With HSBC Holdings plc, SABMiller PLC & GlaxoSmithKline plc!
Sep-01-15 03:51AM  Why Now Is The Perfect Time For Me To Buy GlaxoSmithKline plc And Dechra Pharmaceuticals plc
Aug-27-15 04:23PM  Expect Perrigo To Grow, With Or Without Hostile Mylan at Investor's Business Daily
11:24AM  Germany Helps Eurozone Business Activity Rise in August Market Realist
Aug-26-15 01:53PM  Glaxo in $1 Billion Ofatumumab Deal With Novartis at Investopedia
08:44AM  GlaxoSmithKline Lines Its Pockets Courtesy of Novartis Once Again at Motley Fool
Aug-25-15 02:34PM  Nine Explanations For Why The FDA Is Approving Almost Every New Drug Application at Forbes
Aug-21-15 01:05PM  Novartis could pay more than $1B for GlaxoSmithKline MS drug
12:50PM  Pharmaceutical co. investing $2M in Memphis manufacturing facility previously for sale at
06:39AM  European Stocks Fall Further as Volatility Outweighs Strong Economic Data at TheStreet
03:06AM  Vertex Stock Rises after 2Q15 Results Announcement
Aug-19-15 01:11PM  UK Inflation Rises to 0.1% in July, yet EWU Falls 0.27%
01:44AM  Should You Invest In 6%+ Yielders Anglo American plc, HSBC Holdings plc, Ashmore Group plc And GlaxoSmithKline plc?
Aug-18-15 05:43PM  Something Big Is Happening With Big Pharma at Motley Fool
12:15PM  A GSK layoff helps launch a new RTP drug developer at
Aug-17-15 02:17PM  GlaxoSmithKline reopens plant where Legionnaires' found
08:43AM  A Reduced Payout Could Be in the Cards for These High-Yield Dividend Stocks at Motley Fool
Aug-14-15 05:30PM  GlaxoSmithKline to reopen plant where Legionnaires' found
10:06AM  Pfizers Revenue Falls by 7% in 2Q15
Aug-13-15 07:29PM  Glaxo: Meds from plant with Legionnaires' bacteria are safe
12:01PM  5 Things GlaxoSmithKline Plc Wants You to Know at Motley Fool
11:47AM  GSK hopes big clinical trial can breath new life into lung drug
Aug-12-15 07:16PM  Glaxo Finds No Legionnaires' Risk at North Carolina Plant at The Wall Street Journal
01:28PM  Glaxo plant with Legionnaires' bacteria is quiet for 2nd day
12:59PM  Make Room for Exelixis in Your Portfolio at Investopedia
11:06AM  Wall Street's China problem; Macy's earnings miss; American Apparel on the ropes
10:41AM  Macy's 'disappointed'; Alibaba's revenue miss; GE sells finance unit
05:17AM  GSK closes US site after discovery of Legionnaires bacteria at Financial Times
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 11Buy14.00365,1065,111,484365,106May 13 12:36 PM
GLAXOSMITHKLINE PLC10% OwnerMar 02Buy18.0692,6741,673,69231,673,853Mar 02 03:45 PM